Travere Therapeutics, Inc. (NASDAQ: TVTX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TRAVERE THERAPEUTICS, INC.

Travere Therapeutics, Inc. (NASDAQ: TVTX)
Listen to this Section


$58.99
+1.2950 ( +2.25% ) 847.5K

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

Market Data


Open $58.99
Previous Close $57.69
Volume 847.5K
Market Cap $5.36B
Day Range $57.01 - $59.42
52 Week Range $14.36 - $59.42
Shares Outstanding 92.99M
Change % +2.25%
Net Change ▲ 1.2950
Insider Ownership -0.02%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2003
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -218,171.00

Date Type Amount Purchased Purchaser
2023-09-05 Sale -3300.00 REED ELIZABETH E
2023-09-05 Sale -9900.00 Dube Eric M

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 06, 2025
4 Insider transactions 1 Nov 04, 2025
4 Insider transactions 1 Nov 04, 2025
4 Insider transactions 1 Oct 30, 2025
10-q Quarterly Reports 95 Oct 30, 2025
8-k 8K-related 14 Oct 30, 2025
4 Insider transactions 1 Oct 30, 2025
4 Insider transactions 1 Sep 24, 2025
4 Insider transactions 1 Sep 24, 2025
8-k 8K-related 12 Sep 10, 2025

Latest News